The early impact of COVID-19 on the incidence, prevalence, and severity of alcohol use and other drugs: A systematic review

Publikation: Beitrag in FachzeitschriftÜbersichtsartikel (Review)BeigetragenBegutachtung

Beitragende

  • Rose A. Schmidt - , University of Toronto (Autor:in)
  • Rosalie Genois - , Université de Sherbrooke (Autor:in)
  • Jonathan Jin - , University of Toronto (Autor:in)
  • Daniel Vigo - , University of British Columbia (Autor:in)
  • Jürgen Rehm - , Professur für Behaviorale Epidemiologie, University of Toronto, Technische Universität Dresden, Sechenov First Moscow State Medical University, Agència de Salut Pública de Barcelona (ASPB), Universität Hamburg (Autor:in)
  • Brian Rush - , University of Toronto (Autor:in)

Abstract

Background: The aim of this paper was to examine the early impact of COVID-19 on substance use to assess implications for planning substance use treatment and support systems. Method: A systematic review of literature published up to March 2021 was conducted to summarize changes in prevalence, incidence, and severity of substance use associated with COVID-19 and the accompanying public health measures, including lockdown, stay-at-home orders, and social distancing. Results: We identified 53 papers describing changes to substance use at the population level. The majority of papers described changes related to alcohol use and most relied on self-reported measures of consumption during the COVID-19 pandemic, compared with pre-pandemic use. There was less evidence to support changes in non-alcohol substance use. In general, risky pre-pandemic alcohol use, caregiving responsibilities, stress, depression, anxiety, and current treatment for a mental disorder were found to be associated with increased substance use. Conclusion: This review provides preliminary data on changes in substance use, indicating that certain segments of the population increased their alcohol use early on in the COVID-19 pandemic and may be at greater risk of harm and in need of additional services. There is a need for additional population-level information on substance use to inform evidence-based rapid responses from a treatment system perspective.

Details

OriginalspracheEnglisch
Aufsatznummer109065
FachzeitschriftDrug and alcohol dependence
Jahrgang228
PublikationsstatusVeröffentlicht - 1 Nov. 2021
Peer-Review-StatusJa

Externe IDs

PubMed 34600257

Schlagworte

Schlagwörter

  • COVID-19, Health services needs and demand, Pandemics, Prevalence, Substance-related disorders, Systematic review